M. C. JOHNSON CO., INC. – Trademark Portfolio
Entity Type: 03
M. C. JOHNSON CO., INC. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 8 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include NG SECURE, CATH-SECURE, WOUND-SECURE, SHIELD-SECURE, and CATH-SECURE PLUS. The owner is based in LEOMINSTER, MA.
695 LANCASTER STREET
LEOMINSTER, MA 01453
Showing of trademarks Trademarks
Trademark Classifications
M. C. JOHNSON CO., INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Frequently Asked Questions
How many trademarks does M. C. JOHNSON CO., INC. have?
M. C. JOHNSON CO., INC. has 14 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 abandoned, 7 cancelled.
What trademark classes does M. C. JOHNSON CO., INC. file in?
M. C. JOHNSON CO., INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 11 (Environmental Control). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are M. C. JOHNSON CO., INC.'s most well-known trademarks?
M. C. JOHNSON CO., INC.'s registered trademark portfolio includes well-known marks such as NG SECURE, CATH-SECURE, WOUND-SECURE, SHIELD-SECURE, and CATH-SECURE PLUS. These are among 6 currently registered trademarks in the portfolio.
What is M. C. JOHNSON CO., INC.'s trademark registration success rate?
M. C. JOHNSON CO., INC. has a 43% trademark registration rate, with 6 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.